Additionally, the 36-month beta value for ISPC is 1.67. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ISPC is 5.33M and currently, short sellers hold a 0.29% ratio of that float. The average trading volume of ISPC on April 04, 2024 was 140.58K shares.
ISPC) stock’s latest price update
The stock of iSpecimen Inc (NASDAQ: ISPC) has decreased by -8.64 when compared to last closing price of 0.24.Despite this, the company has seen a loss of -6.51% in its stock price over the last five trading days. GlobeNewsWire reported 2024-03-12 that The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern
ISPC’s Market Performance
ISPC’s stock has fallen by -6.51% in the past week, with a monthly drop of -52.75% and a quarterly drop of -57.89%. The volatility ratio for the week is 10.76% while the volatility levels for the last 30 days are 13.87% for iSpecimen Inc The simple moving average for the past 20 days is -34.28% for ISPC’s stock, with a -69.80% simple moving average for the past 200 days.
ISPC Trading at -46.15% from the 50-Day Moving Average
After a stumble in the market that brought ISPC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.19% of loss for the given period.
Volatility was left at 13.87%, however, over the last 30 days, the volatility rate increased by 10.76%, as shares sank -54.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -54.86% lower at present.
During the last 5 trading sessions, ISPC fell by -6.51%, which changed the moving average for the period of 200-days by -84.75% in comparison to the 20-day moving average, which settled at $0.3233. In addition, iSpecimen Inc saw -55.83% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ISPC starting from Bielak Benjamin, who purchase 18,000 shares at the price of $0.72 back on Sep 14 ’23. After this action, Bielak Benjamin now owns 84,348 shares of iSpecimen Inc, valued at $12,960 using the latest closing price.
Curley Tracy, the CEO, CFO and Treasurer of iSpecimen Inc, purchase 4,400 shares at $1.25 during a trade that took place back on May 31 ’23, which means that Curley Tracy is holding 49,541 shares at $5,500 based on the most recent closing price.
Stock Fundamentals for ISPC
Current profitability levels for the company are sitting at:
- -1.13 for the present operating margin
- 0.46 for the gross margin
The net margin for iSpecimen Inc stands at -1.11. The total capital return value is set at -1.14. Equity return is now at value -73.87, with -54.90 for asset returns.
Based on iSpecimen Inc (ISPC), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -29.59. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -698.04.
Currently, EBITDA for the company is -9.1 million with net debt to EBITDA at 0.22. When we switch over and look at the enterprise to sales, we see a ratio of -0.01. The receivables turnover for the company is 3.38for trailing twelve months and the total asset turnover is 0.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.36.
Conclusion
In conclusion, iSpecimen Inc (ISPC) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
